215
Views
18
CrossRef citations to date
0
Altmetric
Articles

Expression of pleiotrophin, an important regulator of cell migration, is inhibited in intestinal epithelial cells by treatment with non-steroidal anti-inflammatory drugs

, , &
Pages 258-266 | Received 09 Feb 2012, Accepted 11 May 2012, Published online: 13 Jun 2012

References

  • Ashton M, Hanson PJ. 2002. Disparate effects of non-steroidal anti-inflammatory drugs on apoptosis in guinea pig gastric mucous cells: Inhibition of basal apoptosis by diclofenac. Br J Pharmacol. 135:407–416.
  • Cryer B. 2005. NSAID-associated deaths: The rise and fall of NSAID-associated GI mortality. Am J Gastroenterol. 100:1694–1695.
  • Delco F, Michetti P, Beglinger C, Fried M, Szucs TD. 2004. Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. Digestion. 69:10–19.
  • Deuel TF, Zhang N, Yeh H-J, Silos-Santiago I, Wang Z-Y. 2002. Pleiotrophin: A cytokine with diverse functions and a novel signaling pathway. Arch Biochem Biophys. 397:162–171.
  • Dignass AU. 2001. Mechanisms and modulation of intestinal epithelial repair. Inflamm Bowel Dis. 7:68–77.
  • Dineen SP, Lynn KD, Holloway SE, Miller AF, Sullivan JP, Shames DS, Beck AW, Barnett CC, Fleming JB, Brekken RA. 2008. Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. Cancer Res. 68:4340–4346.
  • Fendrick AM, Greenberg BP. 2009. A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis. Osteopath Med Prim Care. 3:1–7.
  • Freeman LC, Narvaez DF, McCoy A, von Stein FB, Young S, Silver K, Ganta S, Koch D, Hunter R, Gilmour RF, Lillich JD. 2007. Depolarization and decreased surface expression of K+ channels contribute to NSAID-inhibition of intestinal restitution. Biochem Pharmacol. 74:74–85.
  • Frey HH, El-Sayed MA. 1977. Concentrations of acidic anti-inflammatory drugs in gastric mucosa. Arch Int Pharmacodyn Ther. 230:300–308.
  • Glading A, Chang P, Lauffenburger DA, Wells A. 2000. Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J Biol Chem. 275:2390–2398.
  • Glading A, Uberall F, Keyse S, Lauffenburger DA, Wells A. 2001. Membrane proximal ERK signaling is required for m-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem. 276:23341–23348.
  • Glading A, Bodnar RJ, Reynolds IJ, Shiraha H, Satish L, Potter DA, Blair HC, Wells A. 2004. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol. 24:2499–2512.
  • Israel LH, Koea JB, Stewart ID, Wright CL, Frankish PD. 2001. Nonsteroidal anti-inflammatory drug-induced strictures of the colon. Dis Colon Rectum. 44:1362–1364.
  • Karcher LF, Dill SG, Anderson WI, King JM. 1990. Right dorsal colitis. J Vet Intern Med. 4:247–253.
  • Kato M, Nishida S, Kitasato H, Sakata N, Kawai S. 2001. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: Investigation using human peripheral monocytes. J Pharm Pharmacol. 53:1679–1685.
  • Kokoska ER, Smith GS, Deshpande Y, Wolff AB, Miller TA. 1998. Indomethacin increases susceptibility to injury in human gastric cells independent of PG synthesis inhibition. Am J Physiol. 275:G620–G628.
  • Lichtenberger LM. 2001. Where is the evidence that cyclooxygenase inhibition is the primary cause of neonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal injury? Topical injury revisited. Biochem Pharmacol. 61:631–637.
  • MacAllister CG, Morgan SJ, Borne AT, Pollet RA. 1993. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J Am Vet Med Assoc. 202:71–77.
  • Mahmud T, Rafi SS, Scott DL, Wrigglesworth JM, Bjarnason I. 1996. Nonsteroidal antiinflammatory drugs and uncoupling of mitochondrial oxidative phosphorylation. Arthritis Rheum. 39:1998–2003.
  • Mikelis C, Sfaelou E, Koutsioumpa M, Kieffer N, Papadimitriou E. 2009. Integrin αvβ3 is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase β/ζ. FASEB J. 23:1459–1469.
  • Pai R, Szabo IL, Giap AQ, Kawanaka H, Tarnawski AS. 2001. Nonsteroidal anti-inflammatory drugs inhibit re-epithelialization of wounded gastric monolayers by interfering with actin, Src, FAK, and tensin signaling. Life Sci. 69:3055–3071.
  • Papadimitriou E, Polykratis A, Hatziapostolou M, Parthymou A, Polytarchou C, Mikelis C. 2004. Heparin affin regulatory peptide: A new target for tumour therapy?. Curr Cancer Drug Tar. 4:471–482.
  • Penney AG, Malcontenti-Wilson C, O'Brien PE, Andrews FJ. 1995. NSAID-induced delay in gastric ulcer healing is not associated with decreased epithelial cell proliferation in rats. Digest Dis Sci. 40:2684–2693.
  • Perez-Pinera P, Berenson JR, Deuel TF. 2008. Pleiotrophin, a multifunctiional angiogenic factor: Mechanisms and pathways in normal and pathobiological angiogenesis. Curr Opin Hematol. 15:210–214.
  • Peskar BM, Maricic N, Gretzera B, Schuligoi R, Schmassmann A. 2001. Role of cyclooxygenase-2 in gastric mucosal defense. Life Sci. 69:2993–3003.
  • Polykratis A, Katsoris P, Courty J, Papadimitriou E. 2005. Characterization of heparin affin regulatory peptide signaling in human endothelial cells. J Biol Chem. 280:22454–22461.
  • Polytarchou C, Hatziapostolou M, Poimenidi E, Mikelis C, Papadopoulou A, Parthymou A, Papadimitriou E. 2009. Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase β/ζ. Int J Cancer. 124:1785–1793.
  • Pufe T, Groth G, Goldring MB, Tillmann B, Mentlein R. 2007. Effects of pleiotrophin, a heparin-binding growth factor, on human primary and immortalized chondrocytes. Osteoarthr Cartilage. 15:155–162.
  • Quaroni A, Wands J, Trelstad RL, Isselbacher KJ. 1979. Epithelioid cell cultures from rat small intestine: Characterization by morphologic and immunologic criteria. J Cell Biol. 80:248–265.
  • Radi ZA. 2009. Pathophysiology of cyclooxygenase inhibition in animal models. Toxicol Pathol. 37:34–46.
  • Rahgozar M, Pazokitoroudi H, Bakhtiarian A, Djahanguiri B. 2001. Diazoxide, a KATP opener, accelerates restitution of ethanol or indomethacin-induce gastric ulceration in rats independent of polyamines. J Gastroenterol Hepatol. 16:290–296.
  • Rao JN, Platoshyn O, Li L, Guo X, Golovina VA, Yuan JX, Wang JY. 2002. Activation of K+ channels and increased migration of differentiated intestinal epithelial cells after wounding. Am J Physiol. 282:C885–C898.
  • Raveendran NN, Silver K, Freeman LC, Narvaez DF, Weng K, Ganta S, Lillich JD. 2008. Drug-induced alterations to gene and protein expression in intestinal epithelial cell 6 cells suggest a role for calpains in the gastrointestinal toxicity of nonsteroidal anti-inflammatory agents. J Pharmacol Exp Ther. 325:389–399.
  • Schmassmann A, Tarnawski AS, Peskar BM, Varga L, Flogerzi B, Halter F. 1995. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: Interaction with indomethacin. Am J Physiol. 268:G276–G285.
  • Silver K, Leloup L, Freeman LC, Wells A, Lillich JD. 2010. Non-steroidal anti-inflammatory drugs inhibit calpain activity and membrane localization of calpain 2 protease. Int J Biochem Cell Biol. 42:2030–2036.
  • Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Masferrer JL, Seibert K, Isakson PC. 1998. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci. 95:13313–13318.
  • Somasundaram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, Rafi S, Roseth A, Foster R, Price AB, Wrigglesworth JM, Bjarnason I. 2000. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibitiion of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharm Ther. 14:639–650.
  • Suh E, Traber PG. 1996. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol Cell Biol. 16:619–625.
  • Suzuki T, Suganuma T, Shimizu R, Aoki M, Hanano M. 1997. Relationship between pharmacokinetics and the analgesic effect of indomethacin in the rat. Biol Pharmacol Bull. 20:438–442.
  • Tanaka A, Araki H, Komoike Y, Hase S, Takeuchi K. 2001. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol Paris. 95:21–27.
  • Tavares IA. 2000. The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis by fresh human gastric mucosa. Aliment Pharm Ther. 14:795–799.
  • Tomisato W, Tsutsumi S, Hoshino T, Hwang HJ, Mio M, Tsuchiya T, Mizushima T. 2004. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem Pharmacol. 67:575–585.
  • Ulbricht U, Eckerich C, Fillbrandt R, Westphal M, Lamszus K. 2006. RNA interference targeting protein tyrosine phosphatase ζ/receptor-type protein tyrosine phosphatase β suppresses glioblastoma growth in vitro and in vivo. J Neurochem. 98:1497–1506.
  • Wallace JL, Vong L. 2008. NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs. Curr Opin Invest Drugs. 9:1151–1156.
  • Whittle BJR. 2003. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Fund Clin Pharm. 17:301–313.
  • Wolfe MM, Lichtenstein DR, Singh G. 1999. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. New Engl J Med. 341:1397–1399.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.